THALES
4.6.2024 09:01:35 CEST | Business Wire | Press release
The United Kingdom government’s Driver and Vehicle Licensing Agency (DVLA) partners with Thales to reduce the carbon footprint of its driving licences as well as tachograph and residence cards. Since 2018, Thales has cut by over one third the CO2 emissions associated with the 12 million cards it supplies to the DVLA every year, without compromising the outstanding security, durability and value-for-money provided by these products.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240604196678/en/
(credit: Shutterstock – Jubemo/Thales)
The DVLA is responsible for maintaining accurate records of more than 52 million drivers in Great Britain and more than 46 million vehicles across the UK. It is also recognised as a centre of excellence for sourcing and issuing secure national documents. Since 2012, Thales has supplied the DVLA with polycarbonate driving licences, a range of tachograph cards (for operations such as recording and storing the activity of commercial drivers), and residence cards for EU citizens to prove their right to live and work in the UK.
Key initiatives undertaken by Thales include adoption of eco-design principles throughout its identity card portfolio. For example, the size of the contactless microcontrollers embedded in the UK’s tachograph and residence cards has been halved, resulting in an equivalent reduction in CO2 microcontroller emissions while maintaining applications and security features unchanged.
In addition, Thales’ factories manufacturing the cards are accredited to the ISO 50001 standard, which focuses on energy efficiency. All these factories use 100% renewably electricity, accounting for over 70% of their total energy consumption. These improvements resulted in a reduction of over 80% of manufacturing related emissions (scope 1 and 2) since 2018.
For the remaining emissions of DVLA cards and on a yearly basis, Thales invests in high quality carbon offsetting programs with independently recognized carbon compensation organization such as Climate Impact Partners. For the DVLA contract, these include planting forests in the UK, restoring mangroves in Kenya, and distributing clean energy stoves in Bangladesh. In total, Thales has now offset 3,000 tonnes of CO2 emissions on behalf of the DVLA.
“Just like the DVLA, Thales is on the road to net zero and uses industry standard tools to calculate the Life Cycle Assessments of its products. This comprehensive calculator1 assesses the environmental impact of materials, packaging, transportation, document production and distribution, as well as end of life. Together with DVLA we are continually exploring new opportunities to improve the sustainability of the millions of cards supplied by Thales, looking for more responsible materials and solutions. At the same time, we remain focused on the need to maintain the security and integrity of identity credentials and deliver exceptional value for money for governments and public bodies” said Nathalie Gosset, Vice President Identity Document Solutions at Thales
1 This approach was developed with Quantis, a leading environmental sustainability consultancy, and is now supported by Solinnen, an expert consultancy specialising in Life Cycle Assessment, following recognised standards which consider the full life cycle of the products assessed and covers associated scope 1, 2 and 3.
About Thales Thales (Euronext Paris: HO) is a global leader in advanced technologies specialized in three business domains: Defence & Security, Aeronautics & Space, and Cybersecurity & Digital identity. It develops products and solutions that help make the world safer, greener and more inclusive. The Group invests close to €4 billion a year in Research & Development, particularly in key innovation areas such as AI, cybersecurity, quantum technologies, cloud technologies and 6G. Thales has close to 81,000 employees in 68 countries. In 2023, the Group generated sales of €18.4 billion. |
PLEASE VISIT
Thales Group
Digital Identity & Security
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240604196678/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Askey and Canoga Perkins Announce Strategic Collaboration at MWC Barcelona to Deliver Rapid-Deploy 5G Critical Communications Solutions27.3.2026 12:00:00 CET | Press release
Askeyand Canoga Perkinsannounced at Mobile World Congress Barcelona a Global Partnership to Deliver SyncMetra® Network Connectivity Solution, combining Canoga Perkins’ software-defined, IT-operated private 5G network transport along with Askey’s carrier-grade 5G radio access technology. At MWC Barcelona 2026, Askey Computer Corporation and Canoga Perkins announced a strategic partnership to deploy Canoga Perkins' SyncMetra® Platform across enterprise and service provider markets with Askey. This partnership pairs Askey’s carrier-grade radio access capabilities with Canoga Perkins’ industry-leading time-sensitive networking (TSN) and synchronization technology, enabling customers to simplify deployment of ultra-low-latency, highly reliable network services for 5G, edge compute, industrial automation, and mission-critical enterprise applications. The partnership enables joint go-to-market efforts, integrated product offerings, and expanded access to SyncMetra through Askey’s sales channe
SBC Medical Announces Fourth Quarter and Full Year 2025 Financial Results27.3.2026 11:40:00 CET | Press release
Q4 EPS more than doubles to $0.14 as profitability improves significantly year over year SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical” or the “Company”), a Management Services Organization operating a wide range of franchise businesses across diverse medical fields, today announced its financial results for the fourth quarter of fiscal year 2025 (three months ended December 31, 2025) and for the full fiscal year 2025 (twelve months ended December 31, 2025). Fourth Quarter 2025 Highlights Total revenues were $40 million, representing an 11% year-over-year decrease. Net Income attributable to SBC Medical Group was $14 million, representing a 117% year-over-year increase. Earnings per share, which is defined as net income attributable to the Company divided by the weighted average number of outstanding shares, was $0.14 for the three months ended December 31, 2025, representing 133% year-over-year increase. EBITDA1, which is calculated by adding depreciation and amo
NIQ Redefines Packaging Intelligence with Monthly, Harmonized Global Performance Visibility27.3.2026 11:00:00 CET | Press release
NIQ’s new solution brings unprecedented clarity into package types, materials, and true consumption across markets, closing critical industry gaps NielsenIQ (NYSE: NIQ), a global leader in consumer intelligence, today announced the launch of its Packaging Strategic Planner Global (SPG) Solution, the first harmonized global platform to deliver monthly visibility into packaging performance across materials, formats, and pack configurations. As packaging innovation accelerates, many organizations continue to rely on fragmented or annual data to inform packaging decisions. The Packaging SPG Solution closes this gap by providing real-time data delivered monthly across regions, enabling brands and packaging partners to uncover trends, grow revenue, and strengthen relationships with CPG and retail partners. Key Highlights: New monthly global packaging tracking capability Coverage across 200+ categories Visibility into 30+ package types and 20 package materials 10+ markets at launch, expanding
European DataWarehouse Claims Its First “Fintech Provider of the Year” Award and a Sixth “Data Provider of the Year” Title at GlobalCapital’s 2026 European Securitisation Awards27.3.2026 08:47:00 CET | Press release
European DataWarehouse (EDW) is pleased to announce that it has been named both “Data Provider of the Year” and “Fintech Provider of the Year” at the 2026 GlobalCapital European Securitization Awards in London. The award ceremony recognises outstanding achievements in European structured finance, with winners selected by popular vote from across the industry. As defined by GlobalCapital, the programme celebrates “the very best in the market, as chosen by the market.” This latest recognition marks the sixth time that EDW has received the prestigious Data Provider of the Year award, having previously been honoured in 2019, 2022, 2023, 2024 and 2025, reaffirming its long-standing commitment to transparency, data quality and innovation in European securitisation. Prof. José Manuel González-Páramo, Chairman of EDW, later commented: “ Winning this award for the sixth time highlights the continued trust the European securitisation market places in EDW. Transparency, data quality and reliabili
Biocytogen Announces FDA IND Clearance for Partner NEOK Bio’s NEOK002 Targeting Solid Tumors27.3.2026 01:00:00 CET | Press release
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315), a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies, today announced that its partner NEOK Bio, Inc. recently received clearance from the U.S. Food and Drug Administration (FDA) of an investigational new drug (IND) application for NEOK002, an EGFR/MUC1-targeting ADC program for solid tumors. NEOK Bio plans to initiate a Phase 1 clinical study in the second quarter of 2026 and expects to report initial data in 2027. This IND clearance marks an important milestone for NEOK002, an EGFR/MUC1-targeting ADC candidate developed by NEOK Bio and built on a bispecific antibody originally developed by Biocytogen and licensed in 2024. According to NEOK Bio, NEOK002 is being advanced for solid tumors and may offer differentiated efficacy and safety compared with monospecific ADC approaches directed at either target alone. Dr. Yuelei Sh
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
